Shares of Venn Life Sciences Holdings PLC (LON:VENN – Get Free Report) passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 6.85 ($0.09) and traded as high as GBX 7 ($0.09). Venn Life Sciences shares last traded at GBX 6.85 ($0.09), with a volume of 1,027,544 shares.
Venn Life Sciences Stock Up 7.0 %
The stock has a market cap of £4.89 million and a P/E ratio of -2.14. The company has a current ratio of 2.30, a quick ratio of 1.48 and a debt-to-equity ratio of 35.83. The stock’s 50-day moving average is GBX 6.85 and its 200-day moving average is GBX 6.85.
About Venn Life Sciences
Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.
See Also
- Five stocks we like better than Venn Life Sciences
- 3 Ways To Invest In Coffee, Other Than Drinking It
- How Whitestone REIT is Transforming Sunbelt Retail Growth
- ETF Screener: Uses and Step-by-Step Guide
- Top-Performing Non-Leveraged ETFs This Year
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Venn Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venn Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.